CUSIP 55287L101COMMBXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
137 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 6.65M | $209.80M | 0 | Held |
| 2 | Orbimed Advisors LLC | 3.94M | $124.12M | −67.7K | Reduced |
| 3 | Nea Management Company, LLC | 3.61M | $114.00M | 0 | Held |
| 4 | Wellington Management Group LLP | 3.35M |
| $105.66M |
| −1.47M |
| Reduced |
| 5 | Deep Track Capital, LP | 3.25M | $102.50M | +99.8K | Added |
| 6 | Blackrock, Inc. | 2.92M | $92.09M | +962.3K | Added |
| 7 | Nvp Associates, LLC | 2.14M | $67.38M | 0 | Held |
| 8 | Ecor1 Capital, LLC | 2.12M | $66.98M | 0 | Held |
| 9 | Vanguard Group Inc | 1.82M | $57.33M | +140.4K | Added |
| 10 | Driehaus Capital Management LLC | 1.41M | $44.41M | −131.5K | Reduced |
See every fund holding Mbx Biosciences Inc, with full quarter-over-quarter share changes.
Unlock all holders